Munir Pirmohamed - Major Publications#
1. PIRMOHAMED, M., JAMES, S., MEAKIN, S., GREEN, C., SCOTT, A.K., WALLEY, T.J., FARRAR, K., PARK, B.K., BRECKENRIDGE, A.M. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 329: 15-19. [2237 citations]
2. THOMAS, J., WANG, L., CLARK, R.E., PIRMOHAMED, M. (2004) Active transport of imatinib into and out of cells: implications for drug resistance. Blood, 104:3739-3745. [597 citations]
3. HUGHES, D.A., VILAR,J., WARD, C.C., ALFIREVIC, A., PARK, B.K., PIRMOHAMED, M. (2004). Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics, 14: 335-342. [230 citations]
4. WANG, L., GIANNOUDIS, A., LANE, S., WILLIAMSON, P., PIRMOHAMED, M. AND CLARK, R.E. (2008) Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia. Clin Pharmacol Ther. 83: 258-264. [257 citations]
5. DAVIES EC, GREEN CF, TAYLOR S, WILLIAMSON PR, MOTTRAM DR, PIRMOHAMED M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 4: e4439. [352 citations]
6. DALY AK, DONALDSON PT, BHATNAGAR P, SHEN Y, PE'ER I, FLORATOS A, DALY MJ, GOLDSTEIN DB, JOHN S, NELSON MR, GRAHAM J, PARK BK, DILLON JF, BERNAL W, CORDELL HJ, PIRMOHAMED M, AITHAL GP, DAY CP. (2009). HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nature Genetics; 41:816-9. [597 citations]
7. INTERNATIONAL WARFARIN PHARMACOGENETICS CONSORTIUM. (2009) Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data. N Engl J Med 360: 753-764 [1079 citations]
8. MCCORMACK M, ALFIREVIC A, BOURGEOIS S, FARRELL JJ, KASPERAVICIUTE D, CARRINGTON M, SILLS GJ, MARSON T, JIA X, DE BAKKER PI, CHINTHAPALLI K, MOLOKHIA M, JOHNSON MR, O'CONNOR GD, CHAILA E, ALHUSAINI S, SHIANNA KV, RADTKE RA, HEINZEN EL, WALLEY N, PANDOLFO M, PICHLER W, PARK BK, DEPONDT C, SISODIYA SM, GOLDSTEIN DB, DELOUKAS P, DELANTY N, CAVALLERI GL, PIRMOHAMED M. (2011). HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. New England Journal of Medicine; 364:1134-43. [468 citations]
9. CARR, D. F., CHAPONDA, M., JORGENSEN, A. L., CASTRO, E. C., VAN OOSTERHOUT, J. J., KHOO, S. H., LALLOO, D. G., HEYDERMAN, R. S., ALFIREVIC, A., & PIRMOHAMED, M. (2013). Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population. Clin Infect Dis, 56, 1330-1339. [37 citations]
10. PIRMOHAMED, M., BURNSIDE, G., ERIKSSON, N., JORGENSEN, A. L., TOH, C. H., NICHOLSON, T., KESTEVEN, P., CHRISTERSSON, C., WAHLSTRÖM, B., STAFBERG, C., ZHANG, J. E., LEATHART, J. B., KOHNKE, H., MAITLAND-VAN DER ZEE, A. H., WILLIAMSON, P. R., DALY, A. K., AVERY, P., KAMALI, F., & WADELIUS, M. (2013). A Randomized Trial of Genotype-Guided Dosing of Warfarin. New England Journal of Medicine, 369(24):2294-303. [346 citations]
